Journal of the Neurological Sciences

Article	Citations
Central nervous system manifestations of COVID-19: A systematic review	524
Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis	358
The neurology of COVID-19 revisited: A proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries	174
Neurotropism of SARS-CoV 2: Mechanisms and manifestations	170
Neuropsychological and neurophysiological correlates of fatigue in post-acute patients with neurological manifestations of COVID-19: Insights into a challenging symptom	170
Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review	159
Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemic	142
Neurological manifestations and COVID-19: Experiences from a tertiary care center at the Frontline	137
COVID-19 related neuroimaging findings: A signal of thromboembolic complications and a strong prognostic marker of poor patient outcome	136
A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications	133
Cerebrospinal fluid in COVID-19: A systematic review of the literature	126
Cerebrospinal fluid findings in COVID-19 patients with neurological symptoms	121
Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic	99
Role of mitochondrial dysfunction, oxidative stress and autophagy in progression of Alzheimer's disease	94
Post-COVID 19 Neurological Syndrome (PCNS); a novel syndrome with challenges for the global neurology community	94
Neurobiology of cue-reactivity, craving, and inhibitory control in non-substance addictive behaviors	76
Posterior reversible encephalopathy syndrome in patients with COVID-19	74
Time to diagnosis and factors affecting diagnostic delay in amyotrophic lateral sclerosis	74
Anosmia is associated with lower in-hospital mortality in COVID-19	70
Teleneurology during the COVID-19 pandemic: A step forward in modernizing medical care	69
COVID-19-associated mild encephalitis/encephalopathy with a reversible splenial lesion	69
Posterior reversible encephalopathy syndrome (PRES) as a neurological association in severe Covid-19	66
Correlations between COVID-19 and burden of dementia: An ecological study and review of literature	64
Neurological involvement associated with COVID-19 infection in children	64
Cerebral venous sinus thrombosis associated with SARS-CoV-2; a multinational case series	64

Powered Air Purifying Respirator (PAPR) restores the N95 face mask induced cerebral hemodynamic alterations among Healthcare Workers during COVID-19 Outbreak	63
COVID-19 in multiple sclerosis patients and risk factors for severe infection	62
Neurology of COVID-19 in Singapore	61
Transient cortical blindness in COVID-19 pneumonia; a PRES-like syndrome: Case report	60
Guillain Barré Syndrome and its variants as a manifestation of COVID-19: A systematic review of case reports and case series	59
Transcranial magnetic stimulation, deep brain stimulation, and other forms of neuromodulation for substance use disorders: Review of modalities and implications for treatment	59
Myasthenic crisis in COVID-19	58
The discerning eye of computer vision: Can it measure Parkinson's finger tap bradykinesia?	56
Has COVID-19 played an unexpected “stroke” on the chain of survival?	56
Venous cerebral thrombosis in COVID-19 patient	52
Susceptibility-weighted imaging reveals cerebral microvascular injury in severe COVID-19	50
Revisiting the role of brain and peripheral Aβ in the pathogenesis of Alzheimer's disease	49
Wernicke-Korsakoff syndrome despite no alcohol abuse: A summary of systematic reports	49
Metabolic stroke or stroke-like lesion: Peculiarities of a phenomenon	49
COVID-19 vaccination in patients with multiple sclerosis: Safety and humoral efficacy of the third booster dose	47
Mediterranean diet adherence, gut microbiota, and Alzheimer's or Parkinson's disease risk: A systematic review	46
Ketamine and nitrous oxide: The evolution of NMDA receptor antagonists as antidepressant agents	45
The association of SARS-CoV-2 infection and acute disseminated encephalomyelitis without prominent clinical pulmonary symptoms	44
miR-34a-5p and miR-125b-5p attenuate Aβ-induced neurotoxicity through targeting BACE1	44
Cerebrospinal fluid in COVID-19 neurological complications: Neuroaxonal damage, anti-SARS-Cov2 antibodies but no evidence of cytokine storm	42
New technologies and Amyotrophic Lateral Sclerosis – Which step forward rushed by the COVID-19 pandemic?	36
Seroconversion and indolent course of COVID-19 in patients with multiple sclerosis treated with fingolimod and teriflunomide	35
Amygdala pathology in amyotrophic lateral sclerosis and primary lateral sclerosis	33
Part II. high-dose methotrexate with leucovorin rescue for severe COVID-19: An immune stabilization strategy for SARS-CoV-2 induced ‘PANIC’ attack	33
Description of 3 patients with myasthenia gravis and COVID-19	32
Parkinson's disease after COVID-19	31
Exosomal TAR DNA-binding protein-43 and neurofilaments in plasma of amyotrophic lateral sclerosis patients: A longitudinal follow-up study	31
The pathophysiology of Parkinson's disease tremor	31
Neuromyelitis optica spectrum disorders	30
Commercially available seizure detection devices: A systematic review	30
Brucellosis	29
COVID-19-associated delayed posthypoxic necrotizing leukoencephalopathy	29
Neurological presentations of COVID-19: Findings from the Spanish Society of Neurology neuroCOVID-19 registry	28
Evolving diagnostic criteria in primary lateral sclerosis: The clinical and radiological basis of “probable PLS”	28
Radiographic and clinical neurologic manifestations of COVID-19 related hypoxemia	27
Consensus on the treatment of dysphagia in Parkinson's disease	27
Cerebral thrombi of cardioembolic etiology have an increased content of neutrophil extracellular traps	27
Does resting state functional connectivity differ between mild cognitive impairment and early Alzheimer's dementia?	27
Inhibition of HERV-K (HML-2) in amyotrophic lateral sclerosis patients on antiretroviral therapy	27
Treatment of intracerebral hemorrhage: Current approaches and future directions	27
Neurological correlates of brain reward circuitry linked to opioid use disorder (OUD): Do homo sapiens acquire or have a reward deficiency syndrome?	27
Neurologic and cognitive sequelae after SARS-CoV2 infection: Different impairment for ICU patients	27
Clinical review of cerebral venous thrombosis in the context of COVID-19 vaccinations: Evaluation, management, and scientific questions	26
Neurology of inflammatory bowel disease	26
Hospital-based observational study of neurological disorders in patients recently vaccinated with COVID-19 mRNA vaccines	26
Phenotypic categorisation of individual subjects with motor neuron disease based on radiological disease burden patterns: A machine-learning approach	26
Intrathecal inflammatory responses in the absence of SARS-CoV-2 nucleic acid in the CSF of COVID-19 hospitalized patients	26
Hyperekplexia and other startle syndromes	26
Associations of serum uric acid with incident dementia and cognitive decline in the ARIC-NCS cohort	25
Multiple internal border zone infarcts in a patient with COVID-19 and CADASIL	25

Guillain-Barré syndrome during the Zika virus outbreak in Northeast Brazil: An observational cohort study	25
Western Pacific ALS-PDC: Evidence implicating cycad genotoxins	25
Statin treatment and cerebral microbleeds: A systematic review and meta-analysis	25
IgG regulation through FcRn blocking: A novel mechanism for the treatment of myasthenia gravis	25
Demographic and social determinants of cognitive dysfunction following hospitalization for COVID-19	24
Hypermetabolism is a reality in amyotrophic lateral sclerosis compared to healthy subjects	24
Immunosuppression in chronic autoimmune neurological disorders during the COVID-19 pandemic	24
Early detection of cognitive decline in mild cognitive impairment and Alzheimer's disease with a novel eye tracking test	23
Serotonin syndrome in two COVID-19 patients treated with lopinavir/ritonavir	23
Flare of myasthenia gravis induced by COVID-19 vaccines	23
The relationship between neurofilament light chain and cognition in neurological disorders: A scoping review	23
The potential impact of enhanced hygienic measures during the COVID-19 outbreak on hospital-acquired infections: A pragmatic study in neurological units	23
Opioid-associated amnestic syndrome: Description of the syndrome and validation of a proposed definition	23
The therapeutic potential of exercise for neuropsychiatric diseases: A review	23
History and current progress of chronic subdural hematoma	22
COVID-19-related and not related Guillain-Barré syndromes share the same management pitfalls during lock down: The experience of Liguria region in Italy	22
White matter hyperintensities in patients with Parkinson's disease: A systematic review and meta-analysis	22
Exploring outcomes and characteristics of myasthenia gravis: Rationale, aims and design of registry – The EXPLORE-MG registry	22
A Rare Case of Acute Hemorrhagic Leukoencephalitis in a COVID-19 Patient	22
Silencing of immune activation with methotrexate in patients with COVID-19	22
Part I. SARS-CoV-2 triggered ‘PANIC’ attack in severe COVID-19	22
Quality of life in multiple sclerosis is dominated by fatigue, disability and self-efficacy	22
The neurology of IGG4-related disease	22
Frequency of dementia in Parkinson's disease: A systematic review and meta-analysis	21
An amyotrophic lateral sclerosis hot spot in the French Alps associated with genotoxic fungi	21
Apathy and its impact on carer burden and psychological wellbeing in primary progressive aphasia	21
Neuropathies of leprosy	21
Prognostic role of the controlling nutritional status score in acute ischemic stroke among stroke subtypes	21
Purulent infectious myositis (formerly tropical pyomyositis)	20
Cognitive impairment in Parkinson's disease: A clinical and pathophysiological overview	20
Current status of vaccines for substance use disorders: A brief review of human studies	20
Monitoring of asymptomatic family members at risk of hereditary transthyretin amyloidosis for early intervention with disease-modifying therapies	20
COQ2 V393A confers high risk susceptibility for multiple system atrophy in East Asian population	19
Cerebral amyloid angiopathy and related inflammatory disorders	19
Drug-induced tremor, clinical features, diagnostic approach and management	19
Diffusion weighted imaging in acute ischemic stroke: A review of its interpretation pitfalls and advanced diffusion imaging application	19
COVID-19 and stroke: Experience in a Ghanaian healthcare system	19
Comparison of fixed cell-based assay to radioimmunoprecipitation assay for acetylcholine receptor antibody detection in myasthenia gravis	19
Psychostimulant use disorder emphasizing methamphetamine and the opioid -dopamine connection: Digging out of a hypodopaminergic ditch	19
Strategies to prevent hemorrhagic transformation after reperfusion therapies for acute ischemic stroke: A literature review	19
The humanistic burden of myasthenia gravis: A systematic literature review	19
Predicting short and long-term mortality after acute ischemic stroke using EHR	19
Primary central nervous system vasculitis – An update on diagnosis, differential diagnosis and treatment	19
Exacerbation of chronic inflammatory demyelinating polyneuropathy in concomitance with COVID-19	18
Real world application of ocrelizumab in multiple sclerosis: Single-center experience of 128 patients	18
Investigating the neuroanatomy underlying proprioception using a stroke model	18
miRNA extracted from extracellular vesicles is a robust biomarker of amyotrophic lateral sclerosis	18
ADC values of benign and high grade meningiomas and associations with tumor cellularity and proliferation – A systematic review and meta-analysis	18
Acute amnestic syndromes	18
Transcranial Doppler velocity and associations with delayed cerebral ischemia in aneurysmal subarachnoid Hemorrhage	18
The clinical utility of exome sequencing and extended bioinformatic analyses in adolescents and adults with a broad range of neurological phenotypes: an Australian perspective	18
Risk factors and outcomes of hospitalized stroke patients in Lusaka, Zambia	18
Vagus nerve stimulation: An update on a novel treatment for treatment-resistant depression	18
The CXCL12/CXCR4 axis confers temozolomide resistance to human glioblastoma cells via up-regulation of FOXM1	18
The efficacy of perampanel as adjunctive therapy in drug-resistant focal epilepsy in a “real world” context: focus on temporal lobe epilepsy	18
Acute ischemic stroke and vaccine-induced immune thrombotic thrombocytopenia post COVID-19 vaccination; a systematic review	17
Comparing fluid biomarkers of Alzheimer's disease between African American or Black African and white groups: A systematic review and meta-analysis	17
Impact of motor and nonmotor symptoms in Parkinson disease for the quality of life: The Japanese Quality-of-Life Survey of Parkinson Disease (JAQPAD) study	17
Essential tremor: Clinical perspectives and pathophysiology	17
Prevalence and predictors of post-stroke epilepsy among Ghanaian stroke survivors	17
Sex-dependent characteristics of Neuro-Long-COVID: Data from a dedicated neurology ambulatory service	17
Frequency and factors linked to refractory hypertension among stroke survivors in Ghana	17
Metastases to the central nervous system: Molecular basis and clinical considerations	17
Influence of plasma matrix metalloproteinase levels on longitudinal changes in Alzheimer's disease (AD) biomarkers and cognitive function in patients with mild cognitive impairment due to AD registere	17
Trends in ischemic stroke outcomes in a rural population in the United States	17
Choroid plexus changes on magnetic resonance imaging in multiple sclerosis and neuromyelitis optica spectrum disorder	17
Inflammatory demyelinating polyneuropathy after the ChAdOx1 nCoV-19 vaccine may follow a chronic course	17
Parkinsonism in viral, paraneoplastic, and autoimmune diseases	17
Acute transverse myelitis after BNT162b2 vaccination against COVID-19: Report of a fatal case and review of the literature	16
Autoimmune encephalitis after Japanese encephalitis in children: A prospective study	16
Brain health as a global priority	16
Clinical characteristics, misdiagnosis and outcomes of patients with low-flow spinal arteriovenous fistulas	16
Why does Africa have the lowest number of Neurologists and how to cover the Gap?	16
Zuranolone as an oral adjunct to treatment of Parkinsonian tremor: A phase 2, open-label study	16
Electroconvulsive therapy in treatment resistant depression	16
Serum neurofilament light chain studies in neurological disorders, hints for interpretation	15
Neurocysticercosis. A frequent cause of seizures, epilepsy, and other neurological morbidity in most of the world	15
D-dimer level and outcome of minor ischemic stroke with large vessel occlusion	15
Deep brain stimulation for the treatment of tremor	15
A hypothesis-generating scoping review of miRs identified in both multiple sclerosis and dementia, their protein targets, and miR signaling pathways	15

Toxoplasmosis of the central nervous system: Manifestations vary with immune responses	15
OCT parameters of the optic nerve head and the retina as surrogate markers of brain volume in a normal population, a pilot study	15
Cyclic adenosine monophosphate in acute ischemic stroke: some to update, more to explore	15
The effects of multidisciplinary rehabilitation on neuroimaging, biological, cognitive and motor outcomes in individuals with premanifest Huntington's disease	15
Calcium Channel blockers are associated with reduced risk of Parkinson's disease in patients with hypertension: A population-based retrospective cohort study	14
Myasthenia gravis and azathioprine treatment: Adverse events related to thiopurine S-methyl-transferase (TPMT) polymorphisms	14
Electronic health record derived-impact of COVID-19 on myasthenia gravis	14
False-positive anti-neuronal nuclear antibody type 1 in a patient with RFC1 repeat expansion: Preventing “phenotype creep” in autoimmune neurology	14
Pneumonia risk and its associated factors in Parkinson's disease: A National Database Study	14
Emerging potential mechanisms and predispositions to the neurological manifestations of COVID-19	14
Life stressors significantly impact long-term outcomes and post-acute symptoms 12-months after COVID-19 hospitalization	14
Delayed SARS-COV-2 leukoencephalopathy without Severe Hypoxia	14
The discriminative capacity of CSF β-amyloid 42 and Tau in neurodegenerative diseases in the Chinese population	14
Tremor rating scales and laboratory tools for assessing tremor	14
Assessment of the reporting quality of double-blind RCTs for ischemic stroke based on the CONSORT statement	14
Valproate impact and sex-dependent seizure remission in patients with idiopathic generalized epilepsy	14
Neuropathological explanation of minimal COVID-19 infection rate in newborns, infants and children – a mystery so far. New insight into the role of Substance P	14
Parcellation-based modeling of the supplementary motor area	14
Obstruction-related dysphagia in inclusion body myositis: Cricopharyngeal bar on videofluoroscopy indicates risk of aspiration	14
Long-term safety and efficacy of safinamide as add-on therapy in levodopa-treated Japanese patients with Parkinson's disease with wearing-off: Results of an open-label study	13
Neurological impact of emboli during adult cardiac surgery	13
Novel fluid biomarkers to differentiate frontotemporal dementia and dementia with Lewy bodies from Alzheimer's disease: A systematic review	13
Analysis of academic publishing output among 1634 successful applicants in the 2011–2018 neurosurgery residency match	13
Reduced dopamine transporter binding predicts early transition to Lewy body disease in Japanese patients with idiopathic rapid eye movement sleep behavior disorder	13
Refractory CIDP: Clinical characteristics, antibodies and response to alternative treatment	13
Hyperdense middle cerebral artery sign and response to combination of mechanical Thrombectomy plus intravenous thrombolysis in acute stroke patients	13
Natural history and epidemiology of the spinocerebellar ataxias: Insights from the first description to nowadays	13
Increased homocysteine levels correlate with cortical structural damage in Parkinson's disease	13
Plasma biomarkers of brain injury in COVID-19 patients with neurological symptoms	13
Glucocorticoids for therapeutic immunosuppression: Clinical pearls for the practicing neurologist	13
Concordance of Mini-Mental State Examination, Montreal Cognitive Assessment and Parkinson Neuropsychometric Dementia Assessment in the classification of cognitive performance in Parkinson's disease	13
Local anesthesia vs general anesthesia during endovascular therapy for acute posterior circulation stroke	13
Muscle MRI in two SMA patients on nusinersen treatment: A two years follow-up	13
Impaired topographic organization in Parkinson's disease with mild cognitive impairment	13
Ocular myasthenia gravis – How effective is low dose prednisone long term?	13
Efficacy and safety of 5-Hydroxytryptophan on levodopa-induced motor complications in Parkinson's disease: A preliminary finding	13
Personalizing ocrelizumab treatment in Multiple Sclerosis: What can we learn from Sars-Cov2 pandemic?	13
CNS fungal infections: A review	13
Monitoring cognitive and psychological alterations in COVID-19 patients: A longitudinal neuropsychological study	13
CNS and PNS manifestation in immune checkpoint inhibitors: A systematic review	13
Microstructural white matter abnormalities in multiple sclerosis and neuromyelitis optica spectrum disorders: Evaluation by advanced diffusion imaging	13
Nerve conduction studies in Guillain-Barré syndrome: Influence of timing and value of repeated measurements	13
Improvement of a decreased anti-oxidative activity by edaravone in amyotrophic lateral sclerosis patients	13
Rare tremors and tremors occurring in other neurological disorders	13
Cerebral vascular reactivity and the migraine-stroke relationship: A narrative review	13
Effects of multimodal balance training supported by rhythmical auditory stimuli in people with advanced stages of Parkinson's disease: a pilot randomized clinical trial	13
Improving functional disability in patients with tremor: A clinical perspective of the efficacies, considerations, and challenges of assistive technology	12
Distinct neural circuits are associated with subclinical neuropsychiatric symptoms in Parkinson's disease	12
Review of otential sychedelic reatments for PTSD	12
Can the radiological scale “iNPH Radscale” predict tap test response in idiopathic normal pressure hydrocephalus?	12
Single-dose L-dopa increases upper brainstem GABA in Parkinson's disease: A preliminary study	12
Seizure outcome after epilepsy surgery in tuberous sclerosis complex: Results and analysis of predictors from a multicenter study	12
Impact of thrombus migration on clinical outcomes in patients with internal carotid artery occlusions and patent middle cerebral artery	12
Roles of inflammation in the natural history of intracranial saccular aneurysms	12
Efficacy and tolerability of intravenous brivaracetam for status epilepticus: A systematic review	12
Carotid webs in large vessel occlusion stroke: Clinical, radiological and thrombus histopathological findings	12
Comorbidities worsen the prognosis of generalized myasthenia gravis post-thymectomy	12
The impact of external trigeminal nerve stimulator (e-TNS) on prevention and acute treatment of episodic and chronic migraine: A systematic review	12
Physiologically informed neuromodulation	12
COVID-19 vaccine-related Guillain-Barré syndrome in the Liguria region of Italy: A multicenter case series	12
A comparative study of South African and Portuguese amyotrophic lateral sclerosis cohorts	12
Factors that affect consent rate for organ donation after brain death: A 12-year registry	12
Severe adolescent-onset limb-girdle muscular dystrophy due to a novel homozygous nonsense BVES variant	12
Neurological complications of immune checkpoint inhibitor cancer immunotherapy	12
Focal thalamus pathology in frontotemporal dementia: Phenotype-associated thalamic profiles	12
Identifying prognostic factors and developing accurate outcome predictions for in-hospital cardiac arrest by using artificial neural networks	12
An uncommon disease included commonly in the differential diagnosis of neurological diseases: Neuro-Behçet's syndrome	12
Prevalence of carotid web in a French cohort of cryptogenic stroke	12
Visual fields and optical coherence tomography (OCT) in neuro-ophthalmology: Structure-function correlation	12
A multi-center case series of sarcoid optic neuropathy	12
Increased cerebral integrity metrics in poliomyelitis survivors: putative adaptation to longstanding lower motor neuron degeneration	12
Prevalence and predictors of statin utilization among patient populations at high vascular risk in Ghana	12
The development of a diversity, equity, and inclusion committee in a neurology department and residency program	11
Clinical utility of serial systemic immune inflammation indices (SSIIi) in the context of post covid-19 neurological syndrome (PCNS)	11
Sonographic and ophthalmic assessment of optic nerve in patients with idiopathic intracranial hypertension: A longitudinal study	11
Italian cohort of Lafora disease: Clinical features, disease evolution, and genotype-phenotype correlations	11
Parkinsonism and cerebrovascular disease	11
Classifying epilepsy pragmatically: Past, present, and future	11
Predictors and outcomes of hemorrhagic stroke in reversible cerebral vasoconstriction syndrome	11
The MDS consensus tremor classification: The best way to classify patients with tremor at present	11
Clinical milestones in Parkinson's disease: Past, present, and future	11
Case-control association study of rare nonsynonymous variants of SCN1A and KCNQ2 in acute encephalopathy with biphasic seizures and late reduced diffusion	11
Mild cognitive impairment, dementia and risk of mortality in essential tremor: A longitudinal prospective study of elders	11
Clinical features, pathophysiology, treatment, and controversies of tremor in dystonia	11
Parkinsonism and dementia	11
Mutations in heat shock protein beta-1 (HSPB1) are associated with a range of clinical phenotypes related to different patterns of motor neuron dysfunction: A case series	11
A multi-center, prospective study on the progression rate of asymptomatic ventriculomegaly with features of idiopathic normal pressure hydrocephalus on magnetic resonance imaging to idiopathic normal	11
Initial deterioration and intravenous methylprednisolone therapy in patients with myasthenia gravis	11
Ketamine as a therapeutic agent for depression and pain: mechanisms and evidence	11
Smell dysfunction in COVID-19 patients: More than a yes-no question	11
Abnormal motor unit firing rates in chronic inflammatory demyelinating polyneuropathy	11
Nutcracker phenomenon with a daily persistent headache as the primary symptom: Case series and a proposed pathogenesis model based on a novel MRI technique to evaluate for spinal epidural venous conge	11
Parkinsonism and motor neuron disorders: Lessons from Western Pacific ALS/PDC	11
Non-invasive electrical stimulation of peripheral nerves for the management of tremor	11
Personalized and translational approach for malignant brain tumors in the era of precision medicine: the strategic contribution of an experienced neurosurgery laboratory in a modern neurosurgery and n	11